Cyclopropane

Cyclopropane

SCHEMBL1169924

C1CC1.CN

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylamine SCHEMBL15327586 1.00
Cyclohexane SCHEMBL726714 1.00
Cyclopentane SCHEMBL3380515 1.00
Cycloheptane SCHEMBL4390137 1.00
Methylamine SCHEMBL4254577 1.00
Cyclohexane SCHEMBL50022 1.00
Cyclopropane SCHEMBL1169902 0.93
Cyclohexane SCHEMBL11670358 0.93
Cyclohexane SCHEMBL28645734 0.93
Cyclopropane SCHEMBL4162108 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115957592-A Dealkalization refining agent, preparation method thereof and application thereof in dealkalization of impurities from dry gas 中国石油化工股份有限公司 2023-04-14 CN claimed
CN-115957617-A Dealkalized refining agent and preparation method and application thereof 中国石油化工股份有限公司 2023-04-14 CN claimed
CN-115957590-A Dealkalized refining agent and preparation and application thereof 中国石油化工股份有限公司 2023-04-14 CN claimed
CN-1558898-A Antiviral agent ��Ұ����ҩ��ʽ���� 2004-12-29 CN claimed
US-12162838-B2 Human plasma kallikrein inhibitors BIOCRYST PHARMACEUTICALS, INC. (US) 2024-12-10 US disclosed
CN-115957592-B Dealkalization refined preparation, preparation method thereof and application thereof in dealkalization impurity of dry gas 中国石油化工股份有限公司 2024-11-29 CN disclosed
CN-115957617-B Dealkalization refined preparation and preparation method and application thereof 中国石油化工股份有限公司 2024-11-29 CN disclosed
US-20240150295-A1 HUMAN PLASMA KALLIKREIN INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION 2024-05-09 US disclosed
US-11708333-B2 Human plasma kallikrein inhibitors BIOCRYST PHARMACEUTICALS, INC. (US) 2023-07-25 US disclosed
CN-115957592-A Dealkalization refining agent, preparation method thereof and application thereof in dealkalization of impurities from dry gas 中国石油化工股份有限公司 2023-04-14 CN disclosed
CN-115957617-A Dealkalized refining agent and preparation method and application thereof 中国石油化工股份有限公司 2023-04-14 CN disclosed
CN-115957720-A Dealkalizing refining agent and preparation method and application thereof 中国石油化工股份有限公司 2023-04-14 CN disclosed
CN-1391563-A Therapeutic quinazoline derivatives ASTRAZENECA AB (SE) 2003-01-15 CN disclosed
CN-1096855-C Composition for treating and inducing nitric oxide synthase expression and application thereof MEDINOX INC (US) 2002-12-25 CN disclosed
CN-1311773-A Neuropeptide Y5 receptor antagonists SCHERING CORP (US) 2001-09-05 CN disclosed
CN-1060761-C New aryl (alkyl) propylamides process for preparing them and pharmaceutical compositions containing them ADIR ET COMPAGUIE (FR) 2001-01-17 CN disclosed
CN-1265648-A Conjugaes of dithiocarbamates with pharmacologically active agents and uses therefor MEDINOX INC (US) 2000-09-06 CN disclosed
CN-1265658-A 5-naphthalen-1-yl-1, 3-dioxane derivatives, process for their preparation and their use in therapy SANNOFFE SYNTHELABO (FR) 2000-09-06 CN disclosed
CN-1202824-A Combinational therapeutic methods employing nitric oxide scavengers MEDINOX INC (US) 1998-12-23 CN disclosed
CN-1145897-A New aryl (alkyl) propylamides process for preparing them and pharmaceutical compositions containing them ADIR (FR) 1997-03-26 CN disclosed